BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37310583)

  • 21. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
    Neong SF; Adebayo D; Wong F
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current ascites therapy].
    Ochs A
    Praxis (Bern 1994); 1997 Jan; 86(4):94-7. PubMed ID: 9064726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and management of patients with refractory ascites.
    Senousy BE; Draganov PV
    World J Gastroenterol; 2009 Jan; 15(1):67-80. PubMed ID: 19115470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ascites is usually caused by an underlying liver cirrhosis. Salt restriction and diuretics is the basis for treatment].
    Schult A; Friis-Liby I
    Lakartidningen; 2016 Mar; 113():. PubMed ID: 26978810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of ascites in children.
    Lane ER; Hsu EK; Murray KF
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1281-92. PubMed ID: 26325252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rational diuretic therapy in patients with liver cirrhosis].
    Vogt B; Reichen J
    Ther Umsch; 2000 Jun; 57(6):355-60. PubMed ID: 10894019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.
    Pose E; Cardenas A
    Dig Dis; 2017; 35(4):402-410. PubMed ID: 28468013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of refractory ascites.
    Wong F
    Clin Mol Hepatol; 2023 Jan; 29(1):16-32. PubMed ID: 35676862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ascites: pathogenesis and therapeutic principles.
    Møller S; Henriksen JH; Bendtsen F
    Scand J Gastroenterol; 2009; 44(8):902-11. PubMed ID: 19479632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascites and Hepatorenal Syndrome.
    Adebayo D; Neong SF; Wong F
    Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascitic fluid filtration and intravenous infusion versus total-volume paracentesis with infusion of plasma expander in cirrhosis with tense or intractable ascites.
    Mehta NN; Abraham P; Ashar VJ; Shikare SS; Savant SS; Karnad DR; Mistry FP
    Indian J Gastroenterol; 1998; 17(3):93-6. PubMed ID: 9695389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
    Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current concepts in the management of refractory cirrhotic ascites.
    Oguntona SA; Alebiosu CO
    Niger J Med; 2006; 15(3):197-202. PubMed ID: 17111742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis in patients with portal hypertension].
    Kim YS
    Korean J Gastroenterol; 2010 Sep; 56(3):168-85. PubMed ID: 20847607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized prospective study].
    Choi CH; Han KH; Kim DY; Cho JH; Cheong JY; Song KH; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):52-60. PubMed ID: 12499817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.